Evidence map›Paper›PMID 35904857›Full record

Observational studyJMIR public health and surveillance2022

Bridging the Gap in End Tuberculosis Targets in the Elderly Population in Eastern China: Observational Study From 2015 to 2020.

Kui Liu, Zhenhua Xie, Bo Xie, Songhua Chen, Yu Zhang, Wei Wang, Qian Wu, Gaofeng Cai, Bin Chen

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in JMIR public health and surveillance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mass Tuberculosis Screening Among the Elderly: A Population-Based Study in a Well-Confined, Rural County in Eastern China.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  10. Ending Tuberculosis in Older People: New Strategies for an Age-old Disease.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kui Liu *Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.ORCID 0000-0001-9833-1251
Zhenhua Xie *Ningbo Yinzhou No 2 Hospital, Ningbo, China.ORCID 0000-0002-5634-3470
Bo XieSchool of Urban Design, Wuhan University, Wuhan, China.ORCID 0000-0001-7641-5139
Songhua ChenZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.ORCID 0000-0002-4847-7065
Yu ZhangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.ORCID 0000-0001-7203-454X
Wei WangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.ORCID 0000-0003-3748-6465
Qian WuZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.ORCID 0000-0002-7626-9060
Gaofeng Cai *Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.ORCID 0000-0001-5779-5578
Bin Chen *Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.ORCID 0000-0002-3761-0465
Zhejiang Center for Disease Control and Prevention · CNNingbo No. 2 Hospital · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith a progressive increase in the aging process, the challenges posed by pulmonary tuberculosis (PTB) are also increasing for the elderly population.

objectiveThis study aimed to identify the epidemiological distribution of PTB among the elderly, forecast the achievement of the World Health Organization's 2025 goal in this specific group, and predict further advancement of PTB in the eastern area of China.

methodsAll notified active PTB cases aged ≥65 years from Zhejiang Province were screened and analyzed. The general epidemiological characteristics were depicted and presented using the ArcGIS software. Further prediction of PTB was performed using R and SPSS software programs.

resultsAltogether 41,431 cases aged ≥65 years were identified by the surveillance system from 2015 to 2020. After excluding extrapulmonary TB cases, we identified 39,832 PTB cases, including laboratory-confirmed (23,664, 59.41%) and clinically diagnosed (16,168, 40.59%) PTB. The notified PTB incidence indicated an evident downward trend with a reduction of 30%; however, the incidence of bacteriologically positive cases was steady at approximately 60/100,000. Based on the geographical distribution, Quzhou and Jinhua Cities had a higher PTB incidence among the elderly. The delay in PTB diagnosis was identified, and a significantly prolonged treatment course was observed in the elderly. Moreover, a 50% reduction of PTB incidence by the middle of 2024 was predicted using a linear regression model. It was found that using the exponential smoothing model would be better to predict the PTB trend in the elderly than a seasonal autoregressive integrated moving average model.

conclusionsMore comprehensive and effective interventions such as active PTB screening combined with physical checkup and succinct health education should be implemented and strengthened in the elderly. A more systematic assessment of the PTB epidemic trend in the elderly population should be considered to incorporate more predictive factors.

Indexed as

TuberculosisTuberculosis, PulmonaryAgedChinaForecastingHumansIncidenceelderly populationpredictionpulmonary tuberculosis

Identifiers

PMID35904857
PMCPMC9377476
OpenAlexW4288698983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.